Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin E Ferner

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|May 4, 2019
Antithrombotic dose: Some observations from published clinical trialsSimon B Dimmitt, Christopher N Floyd, Robin E Ferner
Clinical Medicine (London, England)|January 25, 2012
A 63-year-old man with hypomagnesaemia and seizuresNirmalan Arulanantham, Mark Anderson, Neil Gittoes, et al.
Nature Reviews. Drug Discovery|March 31, 2012
Defining rewardable innovation in drug therapyJeffrey K Aronson, Robin E Ferner, Dyfrig A Hughes
BMJ (Clinical Research Ed.)|April 22, 2011
Management of paracetamol poisoningRobin E Ferner, James W Dear, D Nicholas Bateman
Clinical Toxicology (Philadelphia, Pa.)|March 26, 2019
The relationship between antemortem and postmortem morphine concentrationsNigel J Langford, Stephen R Morley, Robin E Ferner
Drug Safety|October 10, 2018
Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and WalesRobin E Ferner, Tohfa Ahmad, Zainab Babatunde, et al.
BMJ Case Reports|July 4, 2012
Recurrent Kikuchi-Fujimoto diseaseBrendan Boyd Spooner, Imdadur Rahman, Nigel Langford, et al.
British Journal of Clinical Pharmacology|September 24, 2021
Free-of-charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experienceSimon O'Callaghan, Robin E Ferner, Andrew Barron, et al.
Drug Safety|March 23, 2011
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UKTehreem F Butt, Anthony R Cox, Helen Lewis, et al.
Drug Safety|June 19, 2008
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysisSara Ormerod, Sarah E McDowell, Jamie J Coleman, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|May 4, 2019
Antithrombotic dose: Some observations from published clinical trialsSimon B Dimmitt, Christopher N Floyd, Robin E Ferner
Clinical Medicine (London, England)|January 25, 2012
A 63-year-old man with hypomagnesaemia and seizuresNirmalan Arulanantham, Mark Anderson, Neil Gittoes, et al.
Nature Reviews. Drug Discovery|March 31, 2012
Defining rewardable innovation in drug therapyJeffrey K Aronson, Robin E Ferner, Dyfrig A Hughes
BMJ (Clinical Research Ed.)|April 22, 2011
Management of paracetamol poisoningRobin E Ferner, James W Dear, D Nicholas Bateman
Clinical Toxicology (Philadelphia, Pa.)|March 26, 2019
The relationship between antemortem and postmortem morphine concentrationsNigel J Langford, Stephen R Morley, Robin E Ferner
Drug Safety|October 10, 2018
Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and WalesRobin E Ferner, Tohfa Ahmad, Zainab Babatunde, et al.
BMJ Case Reports|July 4, 2012
Recurrent Kikuchi-Fujimoto diseaseBrendan Boyd Spooner, Imdadur Rahman, Nigel Langford, et al.
British Journal of Clinical Pharmacology|September 24, 2021
Free-of-charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experienceSimon O'Callaghan, Robin E Ferner, Andrew Barron, et al.
Drug Safety|March 23, 2011
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UKTehreem F Butt, Anthony R Cox, Helen Lewis, et al.
Drug Safety|June 19, 2008
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysisSara Ormerod, Sarah E McDowell, Jamie J Coleman, et al.
Pageof 10